![]() |
市場調査レポート
商品コード
1374801
ビデオ喉頭鏡の世界市場 - 2023年~2030年Global Video Laryngoscopes Market -2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
ビデオ喉頭鏡の世界市場 - 2023年~2030年 |
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
|
ビデオ喉頭鏡検査は、臨床医が喉頭を直接観察しない間接喉頭鏡検査の一形態です。その代わりに、経鼻的または経腔的に挿入された光ファイバーまたはデジタル喉頭鏡を用いて喉頭を可視化します。
ビデオ喉頭鏡(VL)は、気道構造を可視化し、気管内挿管(ETI)を容易にするために、ビデオカメラ技術を利用しています。ビデオ技術の進歩に伴い、より信頼性が高く、高性能で、安価なビデオ喉頭鏡が市場に出回るようになってきています。
ビデオ喉頭鏡は、気道管理が困難な場面で特に有利です。ビデオ喉頭鏡は声門をよりよく観察できるため、解剖学的な変化や開口制限、血液や分泌物、浮腫による視認不良の状況を容易に把握することができます。これにより、気道の課題を迅速に特定して対処することができ、合併症のリスクを低減し、患者の安全性を向上させることができます。
喉頭がんの有病率の増加は、予測期間中に市場が成長するための重要な促進要因の1つです。一般的な喉頭疾患には、喉頭炎、声帯結節、声帯ポリープ、ラインケ浮腫、喉頭蓋嚢腫などがあります。さらに、喉頭疾患の有病率は男性で高いことが観察されています。
例えば、米国がん協会によると、2023年には米国で約1万2,470例(男性9,990例、女性2,480例)の喉頭がんが新たに発生すると推定しています。喉頭がんの約60%は声門(声帯を含む部分)から発生し、約35%は声門上(声帯の上方)で発生します。
喉頭内視鏡検査では、声帯またはその近傍の咽頭部位の生検サンプルを採取し、さらにがんを検出します。このように、喉頭疾患の有病率の増加は、喉頭鏡市場を世界的に加速させる態勢を整えており、今後も増加すると予想されるため、予測期間中に調査された市場の成長を促進します。
さらに、ビデオ喉頭鏡市場は様々な要因によって牽引されています。また、市場プレーヤーによる革新的な製品の導入とともに、直接喉頭鏡手順よりもこれらのデバイスの安全性と優位性を示す出版物や研究が増加していることが、これらの製品の世界の採用率上昇に寄与しています。この採用は、カートベースのディスプレイモデルとは対照的に、一体型ビデオディスプレイの促進や、Intersurgical Ltd.の「I-vieW」のような完全使い捨てデバイスのイントロダクションよってさらに増強されています。
ビデオ喉頭鏡市場の成長を制限する主な要因の1つは、新興国での麻酔用ビデオ喉頭鏡の採用率が低いことです。メドトロニックのデータによると、再利用可能なデバイスのコストは、その技術的専門性によって1,050米ドル~80億5,000万米ドルであり、従来のシングルユースの喉頭鏡のコストは1,850万米ドルです。
その結果、これらの機器の高コストとそのメンテナンスがビデオ喉頭鏡市場の妨げになると予想されます。同時に、気管内挿管用の費用対効果の高い代替デバイスが利用可能であることが、ビデオ喉頭鏡市場の成長機会を阻害する主な要因となっています。
Video laryngoscopy is a form of indirect laryngoscopy in which the clinician does not directly view the larynx. Instead, visualization of the larynx is performed with a fiberoptic or digital laryngoscope inserted transnasally or transorally.
Video laryngoscopy (VL) utilizes video camera technology to visualize airway structures and facilitate endotracheal intubation (ETI). Given the advances in video technology, more reliable, powerful, and less expensive video laryngoscopes are emerging on the market with increasing availability.
Video laryngoscopes can be particularly advantageous in difficult airway management scenarios. They offer a better view of the glottis, making it easier to navigate anatomical variations, limited mouth opening, or situations with poor visualization due to blood, secretions, or edema. This can help in identifying and addressing airway challenges promptly, reducing the risk of complications and improving patient safety.
The rise in the prevalence of laryngeal cancer is one of the significant key drivers that helps the market to grow during the forecast period. Some common laryngeal diseases include laryngitis, vocal nodules, vocal polyps, Reinke's edema, and epiglottic cyst, among others. In addition, it has been observed that the prevalence of laryngeal disease is higher in males.
For instance, according to the American Cancer Society, it estimates in 2023, there will be about 12,470 new cases of laryngeal cancer (9,990 in men and 2,480 in women) in the United States. About 60% of laryngeal cancers start in the glottis (the area containing the vocal cords), while about 35% develop in the supraglottic area (above the vocal cords).
Laryngoscopy takes biopsy samples of the vocal cords or nearby parts of the throat to detect cancer further. Thus, the increasing prevalence of laryngeal disease is poised to accelerate the laryngoscope market globally and is expected to increase in the future, thereby driving the growth of the market studied over the forecast period.
Furthermore, the video laryngoscope market is driven by various factors Also, the growing publications and studies indicating the safety and superiority of these devices over direct laryngoscopy procedures, along with the introduction of innovative products by market players, have been instrumental in the higher adoption of these products globally. This adoption is further augmented by the facilitation of an integrated video display, as opposed to cart-based display models, and the introduction of fully disposable devices such as the "I-vieW' by Intersurgical Ltd.
One of the major factors limiting the growth of the video laryngoscope market is the lower adoption of anaesthesia video laryngoscopes in emerging countries due to their high cost and a lack of favourable reimbursement policies to provide coverage. According to Medtronic data, the cost of reusable devices ranges from USD 1,050 to USD 8,050 Mn depending on their technical speciality, compared to the cost of a single-use traditional laryngoscope, which is USD 18.5 Mn.
As a result, the high cost of these devices, as well as their maintenance, are expected to hamper the video laryngoscope market. At the same time, the availability of cost-effective alternate devices for endotracheal intubation is a major restraining factor for the video laryngoscope market growth opportunities.
The global video laryngoscopes is segmented based on device type, usage, channel type, end-user and region.
The flexible video laryngoscope segment from the device type segment accounted for 41.2% and it is expected to be dominated during the forecast period. It enables the user to visualize biopsy tissue, and abnormalities, or aid in the removal of small growths, such as polyps, from the region, thus propelling growth. The additional advantage is that the camera can be precisely manipulated, enabling the doctor a clear and complete view of the motion of the vocal cords. These factors are expected to drive the segment growth over the forecast period.
For instance, in April 2023, Verathon, a global leader in airway management solutions, announced the launch of the GlideScope Spectrum QC with QuickConnect technology. This new, extensive portfolio of single-use video laryngoscopes features a unique, magnetic connector coupled with image quality enhancements to support fast, effective airway management.
The new Spectrum QC operates seamlessly with Verathon's GlideScope Core™ visualization system, the most comprehensive and flexible airway visualization system for video laryngoscopy, bronchoscopy, and dual-view airway procedures.
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the higher adoption rate of advanced devices, collaborations with key players, novel product launches in emerging markets greater affordability among patients, developed healthcare infrastructure, and constant focus of market players on the U.S
For instance, in June 2023, Teleflex Incorporated a leading global provider of medical technologies, announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. As the exclusive U.S. distributor of the Insighters Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.
Moreover, in July 2020, Nihon Kohden, a U.S. market leader in precision medical products and services, announced that it is offering the NK AWS-S200 video laryngoscope as part of its critical care portfolio. Designed for the safe and secure intubation of patients in even the most difficult situations, the NK AWS-S200 may reduce the exposure to aerosolized particles ii, which can help protect clinicians while intubating patients suffering from COVID-19 or other respiratory infections.
The COVID-19 pandemic brought the video laryngoscope increasingly into mainstream anaesthetic practice. This is a prime opportunity to consolidate the newfound resources and expertise by using a video laryngoscope as a routine intubation device for all patients. Skills degrade over time; therefore, routine use of video laryngoscopes could enable skill maintenance and reinforcement.
The major global players in the Video Laryngoscopes market include: Medtronic Plc, Ambu A/S, Flexicare Group Limited, KARL STORZ SE & Co., Verathon Inc., Nihon Kohden Corporation, Intersurgical Ltd, Hebei Vimed Medical Device Company, Ltd., Infinium Medical, VDO Medical Inc and among others.
The global video laryngoscopes market report would provide approximately 69 tables, 70 figures, and 185 Pages.
LIST NOT EXHAUSTIVE